BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21218344)

  • 1. Toward a mechanism of prion misfolding and structural models of PrP(Sc): current knowledge and future directions.
    Guest WC; Plotkin SS; Cashman NR
    J Toxicol Environ Health A; 2011; 74(2-4):154-60. PubMed ID: 21218344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
    Singh J; Udgaonkar JB
    Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of the pathogenic conformational change of the prion protein by an attractor of low order.
    Havsteen BH
    J Theor Biol; 2004 Nov; 231(1):39-48. PubMed ID: 15363928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling a prion protein dimer: predictions for fibril formation.
    Warwicker J
    Biochem Biophys Res Commun; 2000 Nov; 278(3):646-52. PubMed ID: 11095963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Establishment of a protein misfolding cyclic amplification for PrPSc].
    Han J; Han L; Shi Q; Shi S; Wang X; Zhang BY; Dong XP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):202-4. PubMed ID: 17971920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion protein aggregation and fibrillogenesis in vitro.
    Stöhr J
    Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-sheet constitution of prion proteins.
    Ji HF; Zhang HY
    Trends Biochem Sci; 2010 Mar; 35(3):129-34. PubMed ID: 20060302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of prions in blood.
    Castilla J; Saá P; Soto C
    Nat Med; 2005 Sep; 11(9):982-5. PubMed ID: 16127436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
    Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
    Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mathematical analysis of the dynamics of prion proliferation.
    Greer ML; Pujo-Menjouet L; Webb GF
    J Theor Biol; 2006 Oct; 242(3):598-606. PubMed ID: 16753184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.
    Saborio GP; Permanne B; Soto C
    Nature; 2001 Jun; 411(6839):810-3. PubMed ID: 11459061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of infectious prions: stabilization by domain swapping.
    Yang S; Levine H; Onuchic JN; Cox DL
    FASEB J; 2005 Nov; 19(13):1778-82. PubMed ID: 16260647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics as an approach to study prion protein misfolding and the effect of pathogenic mutations.
    van der Kamp MW; Daggett V
    Top Curr Chem; 2011; 305():169-97. PubMed ID: 21526434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution structure of infectious prion protein: the final frontier.
    Diaz-Espinoza R; Soto C
    Nat Struct Mol Biol; 2012 Apr; 19(4):370-7. PubMed ID: 22472622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.